Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AJJ Medtech Holdings Limited ( (SG:584) ) has issued an announcement.
AJJ Medtech Holdings has announced a leadership reshuffle, with Dr. Tan Wei Jie redesignated as Chief Executive Officer and Executive Director effective 15 May 2026, following the previously disclosed cessation of Ms. Zhao Xin from those roles. The move leaves the overall board and committee structure largely intact, with Chairman and Executive Director Dr. Zhang Jian continuing to lead a board that maintains unchanged audit, remuneration and nominating committees, signaling continuity in corporate governance despite the CEO transition.
More about AJJ Medtech Holdings Limited
AJJ Medtech Holdings Limited is a Singapore-incorporated company operating in the medical technology sector. The group is listed on the Singapore Exchange’s Catalist board and is overseen by a board comprising executive and independent directors, with dedicated audit, remuneration and nominating committees supporting its governance framework.
Technical Sentiment Signal: Sell
Current Market Cap: S$8.56M
For an in-depth examination of 584 stock, go to TipRanks’ Overview page.